Sign Up Now to Download a Free Research Report on
Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts
Having problems viewing PDF files? YM BioSciences, Inc.
YM BioSciences is a drug development company primarily focused on advancing CYT38. The company has recently reported that proxy advisory firms Institutional Investor Services and Glass, Lewis & Co. have recommended that shareholders vote in favor of the Gilead deal.
Going forward ... (see research report)
Subscribe to News Feeds